Cost-effectiveness of diagnostic and therapeutic interventions for chronic hepatitis C: a systematic review of model-based analyses

BACKGROUND: Decisions about which subgroup of chronic hepatitis C (CHC) patients should be treated with direct acting anti-viral agents (DAAs) have economic importance due to high drug prices. Treat-all DAA strategies for CHC have gained acceptance despite high drug acquisition costs. However, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro, Rodolfo, Crathorne, Louise, Perazzo, Hugo, Silva, Julio, Cooper, Chris, Varley-Campbell, Jo, Marinho, Daniel Savignon, Haasova, Marcela, Veloso, Valdilea G., Anderson, Rob, Hyde, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998601/
https://www.ncbi.nlm.nih.gov/pubmed/29895281
http://dx.doi.org/10.1186/s12874-018-0515-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998601/
https://www.ncbi.nlm.nih.gov/pubmed/29895281
http://dx.doi.org/10.1186/s12874-018-0515-9

Ejemplares similares